Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children.

Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children. Abstract Text:

    fong seng limFong Seng Lim,htay htay hanHtay Htay Han,hans l bockHans L Bock,fong seng limFong Seng Lim,htay htay hanHtay Htay Han,hans l bockHans L Bock,

    Introduction: Measles, mumps and rubella (MMR) are viral infections causing significant mortality and morbidity for which effective and safe vaccines are available. The safety, reactogenicity and immunogenicity of a combined MMR vaccine when administered to healthy Singaporean children were evaluated in this study. Materials and Methods: A total of 150 children aged 12 to 18 months were vaccinated in this open, single-group, single-centre study [209762/147]. Solicited local and general symptoms reported within 4 days of vaccination and fever, parotid/salivary gland swelling and signs of meningism in the 43 days following vaccination were recorded using diary cards. Serious adverse events occurring during the study period were monitored. Immunogenicity was assessed at 42 days post-vaccination. Results: Redness (8.7%) and pain (7.2%) at injection site were the most commonly reported solicited local symptoms during the 4-day follow-up period after vaccination. Percentage of subjects reporting drowsiness, irritability and loss of appetite during the 4-day follow-up after vaccination was 7.2%, 8% and 7.2%, respectively. None of the solicited symptoms reported during the 4-day follow-up period was of grade "3" intensity. Fever (42.8%) was the most commonly reported solicited general symptom, with 5.1% of the children reporting fever >39.0 degrees C (axillary). No serious adverse events considered to be related to vaccination were reported. Seroconversion rates were 100% for measles and rubella antibodies and 98.1% for mumps antibodies. Conclusions: GlaxoSmithKline Biologicals' MMR vaccine was shown to be well tolerated and highly immunogenic when used in Singaporean children 12 to 18 months of age.

    Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children. Publishing Authors By Initials

    fs limFS Lim,hh hanHH Han,hl bockHL Bock,fs limFS Lim,hh hanHH Han,hl bockHL Bock,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Annals of the Academy of Medicine, Singapore

    VOLUME: 36

    Page Numbers: 969-5

    Journal Abbreviation: Ann. Acad. Med. Singap.

    ISSN: 0304-4602

    DAY: 10

    MONTH: Dec

    YEAR: 2007

    Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7503289

    Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children.

    AFFILIATION: National Healthcare Group Polyclinics, Singapore.

    Country: Singapore

    Singapore Research PublicationSingapore Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ann Acad Med Singapore

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Safety, Reactogenicity and Immunogenicity of the Live Attenuated Combined Measles, Mumps and Rubella Vaccine Containing the RIT 4385 Mumps Strain in Healthy Singaporean Children Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News